15-min delayed · Aug 25, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Tela Bio Inc, 3 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $1.00 to $3.00 (about 3.0x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $2.00 sits 189% above the current $0.69. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.13 next quarter toward $-0.52 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy375%
Hold125%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Tela Bio Inc.
As of Aug, 3 of 4 firms rate TELA a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
TELA EPS & revenue forecast
EPS · NEXT QUARTER
$-0.13
Range $-0.18 – $-0.10 · 5 analysts · -21% YoY
Next period, 5 analysts expect Tela Bio Inc to earn $-0.13 a share (range $-0.18 – $-0.10), versus $-0.17 a year earlier. Full-year consensus is $-0.70, growing to $-0.52 the year after.
REVENUE · NEXT QUARTER
$21.2M
Range $20.3M – $22.3M · 5 analysts · +2% YoY
Revenue is expected to reach $21.2M (range $20.3M – $22.3M), +1.8% year-over-year. Full-year consensus is $79.6M, rising to $87.1M next year.
Top analysts covering Tela Bio Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on TELA.
#1
CC
Caitlin Cronin
Canaccord Genuity · Rank #187
Buy
$4.00+477.4% to target
Overall win rate
40%
+ Follow
#2
David Turkaly
JMP Securities · Rank #337
Buy
$3.00+333.0% to target
Overall win rate
33%
+ Follow
#3
Frank Takkinen
Lake Street · Rank #381
Buy
$2.00+188.7% to target
Overall win rate
26%
+ Follow
#4
Matt O'Brien
Piper Sandler · Rank #423
Hold
$1.00+44.3% to target
Overall win rate
23%
+ Follow
#5
DT
David Turkaly
Citizens
Buy
$3.00+333.0% to target
Coverage
—
+ Follow
TELA stock forecast FAQ
What is TELA's average 12-month price target?+
The 4 analysts with a live target average $2.00 for Tela Bio Inc over the next 12 months, ranging from a $3.00 high to a $1.00 low.
Is TELA stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 3 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for TELA?+
The Street-high target is $3.00 (Citizens), and the Street-low is $1.00 (Piper Sandler). The average of all 4 active targets is $2.00.
How many Wall Street analysts cover TELA?+
4 analysts have an active rating on Tela Bio Inc, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering TELA?+
Among analysts who currently cover TELA, Caitlin Cronin of Canaccord Genuity has the strongest overall Quantellect track record (Rank #187). Their current call is Buy with a $4.00 target.
What is Tela Bio Inc's projected EPS for next quarter?+
The consensus estimate is $-0.13 per share (range $-0.18 – $-0.10) across 5 analysts. Full-year EPS is projected at $-0.70, rising to $-0.52 the following year.
How much revenue is Tela Bio Inc expected to report next quarter?+
Consensus revenue is $21.2M (range $20.3M – $22.3M). Full-year revenue is projected at $79.6M, growing to $87.1M next year.
Have analysts been upgrading or downgrading TELA lately?+
As of Aug, 3 of 4 firms rate TELA a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their TELA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
